VALID Act 2020 Comprehensive Summary
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
VALID Act
AdvaMedDx VALID Act Webinar, March 20, 2020 – Presentation
On March 5, 2020, the VALID Act was introduced in the Senate and House.
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers…
AdvaMedDx Commends Congress for Proposing Comprehensive Diagnostics Reform and Provides Comments on VALID Act Draft Legislation
Washington, D.C.— AdvaMedDx has submitted comments on draft legislation, the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, commending Congress for their support of comprehensive, risk-based diagnostics regulatory reform. “An overarching,…